184 related articles for article (PubMed ID: 11782935)
1. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19.
Heegaard ED; Qvortrup K; Christensen J
J Med Virol; 2002 Feb; 66(2):246-52. PubMed ID: 11782935
[TBL] [Abstract][Full Text] [Related]
2. Novel PCR assay for differential detection and screening of erythrovirus B19 and erythrovirus V9.
Heegaard ED; Panum Jensen I; Christensen J
J Med Virol; 2001 Oct; 65(2):362-7. PubMed ID: 11536245
[TBL] [Abstract][Full Text] [Related]
3. Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay.
Salimans MM; van Bussel MJ; Brown CS; Spaan WJ
J Virol Methods; 1992 Sep; 39(3):247-58. PubMed ID: 1430069
[TBL] [Abstract][Full Text] [Related]
4. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
Kock WC
J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
[TBL] [Abstract][Full Text] [Related]
5. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
Kerr S; O'Keeffe G; Kilty C; Doyle S
J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic.
Parsyan A; Kerr S; Owusu-Ofori S; Elliott G; Allain JP
J Clin Microbiol; 2006 Apr; 44(4):1367-75. PubMed ID: 16597864
[TBL] [Abstract][Full Text] [Related]
7. Genetic diversity within human erythroviruses: identification of three genotypes.
Servant A; Laperche S; Lallemand F; Marinho V; De Saint Maur G; Meritet JF; Garbarg-Chenon A
J Virol; 2002 Sep; 76(18):9124-34. PubMed ID: 12186896
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control study.
Eden A; Mahr A; Servant A; Radjef N; Amard S; Mouthon L; Garbarg-Chenon A; Guillevin L
Rheumatology (Oxford); 2003 May; 42(5):660-4. PubMed ID: 12709542
[TBL] [Abstract][Full Text] [Related]
9. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
Heegaard ED; Rasksen CJ; Christensen J
J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women.
Jordan JA
J Clin Microbiol; 2000 Apr; 38(4):1472-5. PubMed ID: 10747128
[TBL] [Abstract][Full Text] [Related]
11. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins.
Manaresi E; Zuffi E; Gallinella G; Gentilomi G; Zerbini M; Musiani M
J Med Virol; 2001 May; 64(1):67-73. PubMed ID: 11285571
[TBL] [Abstract][Full Text] [Related]
12. LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates.
Schalasta G; Schmid M; Lachmund T; Enders G
J Med Virol; 2004 May; 73(1):54-9. PubMed ID: 15042648
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a second novel human erythrovirus variant, A6.
Nguyen QT; Wong S; Heegaard ED; Brown KE
Virology; 2002 Sep; 301(2):374-80. PubMed ID: 12359439
[TBL] [Abstract][Full Text] [Related]
14. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.
Ennis O; Corcoran A; Kavanagh K; Mahon BP; Doyle S
J Clin Virol; 2001 Aug; 22(1):55-60. PubMed ID: 11418353
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions.
Kajigaya S; Fujii H; Field A; Anderson S; Rosenfeld S; Anderson LJ; Shimada T; Young NS
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4646-50. PubMed ID: 1711206
[TBL] [Abstract][Full Text] [Related]
16. Detection of parvovirus B19 IgG: choice of antigens and serological tests.
Manaresi E; Gallinella G; Venturoli S; Zerbini M; Musiani M
J Clin Virol; 2004 Jan; 29(1):51-3. PubMed ID: 14675870
[TBL] [Abstract][Full Text] [Related]
17. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.
Söderlund M; Brown CS; Spaan WJ; Hedman L; Hedman K
J Infect Dis; 1995 Dec; 172(6):1431-6. PubMed ID: 7594699
[TBL] [Abstract][Full Text] [Related]
18. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins.
Brown CS; Van Lent JW; Vlak JM; Spaan WJ
J Virol; 1991 May; 65(5):2702-6. PubMed ID: 1901917
[TBL] [Abstract][Full Text] [Related]
19. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.
Ekman A; Hokynar K; Kakkola L; Kantola K; Hedman L; Bondén H; Gessner M; Aberham C; Norja P; Miettinen S; Hedman K; Söderlund-Venermo M
J Virol; 2007 Jul; 81(13):6927-35. PubMed ID: 17409158
[TBL] [Abstract][Full Text] [Related]
20. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
